|
HOOK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.151970E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.290400E-02 |
| Normal-vs-Stage2 |
2.901000E-01 |
| Normal-vs-Stage3 |
4.875000E-03 |
| Normal-vs-Stage4 |
1.341970E-03 |
| Stage1-vs-Stage2 |
8.376600E-01 |
| Stage1-vs-Stage3 |
1.513210E-01 |
| Stage1-vs-Stage4 |
4.799600E-02 |
| Stage2-vs-Stage3 |
2.614800E-01 |
| Stage2-vs-Stage4 |
1.481840E-01 |
| Stage3-vs-Stage4 |
6.080000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.603100E-03 |
| Normal-vs-AfricanAmerican |
9.546000E-01 |
| Normal-vs-Asian |
2.381700E-02 |
| Caucasian-vs-AfricanAmerican |
2.105800E-01 |
| Caucasian-vs-Asian |
9.820800E-01 |
| AfricanAmerican-vs-Asian |
2.340000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.438200E-03 |
| Normal-vs-Female |
4.010300E-02 |
| Male-vs-Female |
9.613900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.534200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.051770E-02 |
| Normal-vs-Age(61-80Yrs) |
9.081900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.701200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.869000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.207400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.414410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.571600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.582600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.638000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.186300E-02 |
| Classical-VS-Follicular |
6.212600E-01 |
| Classical-VS-Other |
5.554400E-01 |
| Classical-VS-Normal |
4.612100E-02 |
| Tall-VS-Follicular |
4.237800E-02 |
| Tall-VS-Other |
7.807200E-01 |
| Tall-VS-Normal |
1.956220E-03 |
| Follicular-VS-Other |
5.278600E-01 |
| Follicular-VS-Normal |
2.847400E-01 |
| Other-VS-Normal |
1.383180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.324100E-02 |
| Normal-vs-N1 |
1.521330E-03 |
| N0-vs-N1 |
1.563380E-01 |
|
|
